Medicare Enrolled
Dr. Timothy Killeen, MD INC
Pulmonary Disease · Temecula, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Killeen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Killeen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Killeen
Dr. Timothy Killeen is a pulmonary disease specialist in Temecula, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Killeen performed 2,823 Medicare services across 1,816 unique beneficiaries.
Between the years covered by Open Payments, Dr. Killeen received a total of $16,787 from 64 pharmaceutical and/or device companies across 845 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Killeen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in CA
$16,787 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,823
Medicare services
Top 13% in CA for pulmonary disease
1,816
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~149 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
962 | $95 | $230 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
583 | $60 | $180 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
352 | $96 | $415 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
232 | $133 | $160 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
97 | $221 | $325 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
81 | $63 | $238 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
63 | $93 | $506 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
62 | $141 | $804 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $113 | $375 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
57 | $102 | $342 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
46 | $39 | $155 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
37 | $159 | $250 |
| Bronchoscopy A diagnostic exam of the lung airways using an endoscope to visually inspect the inside of the lungs and airways. |
35 | $105 | $650 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
35 | $14 | $105 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
31 | $10 | $120 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
31 | $170 | $195 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
25 | $19 | $120 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
24 | $61 | $195 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $60 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,787
Total received (2018-2024)
Avg $2,398/year across 7 years
Top 11% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
845
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,238 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$549 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,521
2023
$2,699
2022
$2,596
2021
$2,082
2020
$1,996
2019
$1,788
2018
$3,105
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$437
Boehringer Ingelheim Pharmaceuticals, Inc.
$240
Takeda Pharmaceuticals U.S.A., Inc.
$224
Actelion Pharmaceuticals US, Inc.
$208
Merck Sharp & Dohme LLC
$198
GENZYME CORPORATION
$176
Bayer Healthcare Pharmaceuticals Inc.
$149
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$127
United Therapeutics Corporation
$119
Grifols USA, LLC
$84
Regeneron Healthcare Solutions, Inc.
$75
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$67
GlaxoSmithKline, LLC.
$59
Insmed, Inc.
$48
Philips North America LLC
$45
Harmony Biosciences Llc
$43
Novartis Pharmaceuticals Corporation
$34
HARMONY BIOSCIENCES LLC
$33
Janssen Pharmaceuticals, Inc
$28
Shionogi Inc
$26
E.R. Squibb & Sons, L.L.C.
$24
MITSUBISHI TANABE PHARMA AMERICA, INC.
$23
Pulmonx Corporation
$22
Baxter Healthcare
$21
Genentech USA, Inc.
$13
Top 3 companies account for 35.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,315
GlaxoSmithKline, LLC.
$1,446
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,272
Actelion Pharmaceuticals US, Inc.
$1,254
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,105
Takeda Pharmaceuticals U.S.A., Inc.
$1,018
United Therapeutics Corporation
$611
Janssen Pharmaceuticals, Inc
$585
Kowa Pharmaceuticals America, Inc.
$539
Regeneron Healthcare Solutions, Inc.
$532
Insmed, Inc.
$506
Grifols USA, LLC
$504
GENZYME CORPORATION
$485
Advanced Respiratory, Inc
$469
PFIZER INC.
$279
Bayer Healthcare Pharmaceuticals Inc.
$274
Merck Sharp & Dohme LLC
$229
Bayer HealthCare Pharmaceuticals Inc.
$218
CSL Behring
$205
Shire North American Group Inc
$204
Allergan Inc.
$202
Genentech USA, Inc.
$181
E.R. Squibb & Sons, L.L.C.
$165
Gilead Sciences, Inc.
$163
Paratek Pharmaceuticals, Inc.
$154
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$144
Melinta Therapeutics, LLC
$133
Baxter Healthcare
$111
SANOFI-AVENTIS U.S. LLC
$110
Mylan Specialty L.P.
$103
Allergan, Inc.
$86
Pulmonx Corporation
$83
Horizon Therapeutics plc
$76
Sunovion Pharmaceuticals Inc.
$75
Amgen Inc.
$72
Novartis Pharmaceuticals Corporation
$71
Circassia Pharmaceuticals Inc
$56
ABBVIE INC.
$52
AbbVie Inc.
$48
Philips North America LLC
$45
Lilly USA, LLC
$43
Harmony Biosciences Llc
$43
Philips Electronics North America Corporation
$38
Eisai Inc.
$37
MAYNE PHARMA INC.
$33
HARMONY BIOSCIENCES LLC
$33
ARBOR PHARMACEUTICALS, INC.
$32
Teva Pharmaceuticals USA, Inc.
$31
Medtronic Vascular, Inc.
$30
PORTOLA PHARMACEUTICALS, INC.
$27
Shionogi Inc
$26
Melinta Therapeutics, Inc.
$23
Horizon Pharma plc
$23
MITSUBISHI TANABE PHARMA AMERICA, INC.
$23
Alexion Pharmaceuticals, Inc.
$21
Inspire Medical Systems, Inc.
$21
Biohaven Pharmaceuticals, Inc.
$20
Novo Nordisk Inc
$17
Breathe Technologies, Inc.
$17
Edwards Lifesciences Corporation
$15
Merck Sharp & Dohme Corporation
$14
Arbor Pharmaceuticals, Inc.
$14
Genentech, Inc.
$13
Electromed, Inc.
$12
Top 3 companies account for 30.0% of all-time payments
Associated products mentioned in payments ›
(O58) Sleep Respiratory Care Und · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Aimovig · AirDuo Digihaler · Arikayce · BELSOMRA · BEVYXXA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CAMZYOS · CHANTIX · CHARTIS CATHETER · COLOGUARD · CUTAQUIG · CUVITRU · Connect HF · DALVANCE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · DreamStat Cpap Auto · Dymista · ELIQUIS · Edarbi · Edarbyclor · Esbriet · FARXIGA · FASENRA · Fetroja · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Volara System · Hizentra · Horizant · INSPIRE · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · Life 2000 Ventilation System · Life2000 Ventilation System · LifeVest · Livalo · MOUNJARO · NIOX VERO · NUCALA · NURTEC ODT · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PRALUENT · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QULIPTA · RADICAVA · RAYOS · Repatha · Respiratoriy Care Undiv · SEGLENTIS · SMARTVEST · SOLIRIS · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TYVASO · The MetaNeb System · The Vest System Model 105 Home Care · Trintellix · UBRELVY · UPTRAVI · Uloric · VIBERZI · Vabomere · WAKIX · WINREVAIR · Wellcentive Undiv · XARELTO · XIFAXAN · XOLAIR · Xolair · Yupelri · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
9
Per 100K population
0.4
County median income
$89,672
Nearest hospital
LOMA LINDA UNIVERSITY MEDICAL CENTER-MURRIETA
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Killeen is a clinical cardiology specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement in the top 11% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Killeen experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Killeen performed 962 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Killeen receive payments from pharmaceutical companies?
Yes. Dr. Killeen received a total of $16,787 from 64 companies across 845 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Killeen's costs compare to other pulmonary diseases in Temecula?
Dr. Killeen's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Killeen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Temecula
Browse pulmonary diseases in Temecula ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology